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Anthrax is a fatal infection of humans and livestock that is caused by the gram-positive bacterium Bacillus
anthracis. The virulent strains of B. anthracis are encapsulated and toxigenic. In this paper we describe the
development of a PCR technique for identifying spores of B. anthracis. Two 20-mer oligonucleotide primers
specific for the capB region of 60-MDa plasmid pXO2 were used for amplification. The amplification products
were detected by using biotin- and fluorescein-labeled probes in a novel dual-probe hybridization format. Using
the combination of PCR amplification and dual-probe hybridization, we detected two copies of the bacterial
genome. Because the PCR assay could detect a minimum of 100 unprocessed spores per PCR mixture, we
attempted to facilitate the release of DNA by comparing the effect of limited spore germination with the effect
of mechanical spore disruption prior to PCR amplification. The two methods were equally effective and allowed
us to identify single spores of B. anthracis in PCR mixtures.
Bacillus anthracis is a gram-positive endospore-forming bac-
terium that is capable of producing fatal infections both in
livestock and in humans (14). At the present time, humans are
infected primarily through contact with products derived from
contaminated animals which are infected after they come into
contact with soil-borne spores. Humans can become infected,
however, when contaminated soil is ingested or inhaled or
comes in contact with an open wound (1). Virulent strains of B.
anthracis are encapsulated and cause death in humans and
animals by producing various toxins, including the lethal factor,
the protective antigen, and the edema factor (9, 17). The
poly-D-glutamic acid capsule and the toxins are encoded by
genes present on two large plasmids, designated pXO2 and
pXO1, respectively (5, 12). The virulence of encapsulated
bacteria has been demonstrated with several species, including
Escherichia coli and Neisseria meningitidis (3, 10). The capsule
of B. anthracis is unique in that it is composed of a ho-
mopolypeptide (D-glutamic acid) (7). Previous studies (11)
have shown that 60-MDa plasmid pXO2 is essential for capsule
formation and that the cap region located on plasmid pXO2
encodes the capsular protein. Three cistrons (capB, capC, and
capA) have been identified within the cap region (11).
There is a growing need for methods to detect B. anthracis
spores and vegetative cells. The development of such methods
should help prevent large-scale livestock destruction and pro-
tect humans who may come into contact with spores and
vegetative cells.
We have previously described (4) the detection of B. anthra-
cis spores by using PCR amplification of a 1.2-kb region of the
edema factor gene. In this paper we describe the development
of a second PCR assay in which a DNA fragment within the
capB gene is targeted. Use of this PCR assay allowed us to
detect single spores of B. anthracis.
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MATERIALS AND METHODS
Bacterial strains and DNA preparations. DNAs from sev-
eral B. anthracis strains (strains Ames, Vollum, New Hamp-
shire, and Sterne) were prepared as previously described (16)
and were kindly provided by Dario Leslie, Chemical and
Biological Defence Establishment, Porton Down, Salisbury,
United Kingdom. Each DNA was ethanol precipitated (16),
vacuum dried, and resuspended in sterile distilled water. The
amounts of DNAs were determined by spectrophotometry or
fluorimetry with a DNA minifluorometer (Hoefer, San Fran-
cisco, Calif.).
For controls, DNAs were extracted (16) from various bac-
terial species, including Clostridium botulinum type A and E
strains ATCC 25763 and ATCC 9564, Yersinia pestis ATCC
19428, Vibrio cholerae ATCC 14035, Bacillus megaterium
ATCC 14581, Bacillus licheniformis ATCC 12759, Bacillus
thuringiensis ATCC 10792, Bacillus cereus ATCC 14579, Bacil-
lus globigii ATCC 9372, and Bacillus subtilis ATCC 6051 (all
obtained from the American Type Culture Collection, Rock-
ville, Md.), as well as Salmonella typhi, Escherichia coli, Shigella
sonnei, Pseudomonas aeruginosa, Klebsiella pneumoniae, Ar-
throbacter globiformis, and Marinococcus halopoilus (all kindly
provided by Richard Haberberger, Bethesda Naval Hospital,
Bethesda, Md.).
Spore preparation and processing. Spores of B. anthracis
Vollum were obtained by seeding vegetative cells onto new
sporulation medium (18) and incubating the preparation at
37°C for 72 h; microscopic examination revealed that approx-
imately 90% sporulation had occurred by this time. The spores
were washed off the agar surface with distilled water and heat
shocked at 60°C for 1 h to kill any vegetative cells present. The
spore preparation was then washed three times with distilled
water and stored at 4°C. The numbers of B. anthracis spores
were determined by direct colony counting, using nutrient
agar.
Various methods for preparing the spores prior to PCR
amplification were analyzed. Aliquots of spores were germi-
nated in phosphate-buffered saline (PBS) supplemented with
300 mM L-alanine and 6 mM ortho-carbamyl-D-serine for 4.5 h
and then boiled for 30 min. Alternatively, spores were physi-
cally disrupted with a mini-bead beater (Biospec Corp., Bar-
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tersville, Okla.) for 10 min at the maximum speed. Each tube
contained 1 ml of glass beads (diameter, 0.1 mm) and 1 ml of
spore suspension. After physical disruption, the supernatants
were removed and used directly as templates for PCR ampli-
fication.
PCR amplification. Two oligonucleotide primers, BACAlFI
(ACAACTGGTACATCTGCGCG; corresponding to nucle-
otides 470 to 489) and BACA6RI (GATGAGGGATCAT
TCGCTGC; corresponding to nucleotides 1073 to 1092), were
constructed on the basis of the sequence of the capsular
antigen gene (capB) of B. anthracis (11). BACAlFI and
BACA6RI (Synthecell Corp., Gaithersburg, Md.) were de-
signed to amplify a 622-bp fragment. PCR amplification of
genomic DNA was initially performed by using a GeneAmp
reagent kit, AmpliTaq polymerase (Perkin Elmer Cetus Corp.,
Norwalk, Conn.), and a model 480 DNA thermal cycler
(Perkin Elmer Cetus Corp.). Template DNA was denatured at
94°C for 4 min, and this was followed by 1 min of annealing at
37°C and extension for 1 min at 72°C. This first step was then
followed by 25 cycles consisting of denaturation at 94°C for 1.5
min, annealing at 55°C for 1 min, and extension at 72°C for 1
min. At the end of 25 cycles, the reaction mixture was kept at
72°C for 7 min to complete synthesis of all of the extended
strands.
Subsequently, PCR amplification of genomic DNA and
spore preparations was accomplished by using 50-,u reaction
mixtures. In the thermal cycle an initial 2-min denaturation
step at 95°C was followed by 35 cycles consisting of denatur-
ation at 95°C for 15 s, annealing at 55°C for 15 s, and extension
at 72°C for 30 s. The final step consisted of extension at 72°C
for 10 min. Amplification experiments were performed by
using Taq polymerase, deoxynucleoside triphosphates (Boehr-
inger Mannheim, Indianapolis, Ind.), and a model 9600 DNA
thermal cycler (Perkin Elmer Cetus Corp.).
Detection of PCR-amplified products. The amplified prod-
ucts were detected by ethidium bromide staining of DNA
separated by polyacrylamide gel electrophoresis (PAGE), as
well as a novel dual-probe hybridization format in which we
used a biosensor capable of detecting minute changes in pH
(Molecular Devices, Menlo Park, Calif.) (13). Electrophoresis
was performed by using 15 to 20 ,ul of PCR product on a 4 to
12% polyacrylamide gel (NOVEX, San Diego, Calif.) and a
constant voltage of 100 V for 1 to 2 h. The gels were stained
with ethidium bromide (1 ,ug/,ul) for 5 to 10 min and were
photographed by using a UV transilluminator and type 665
film (Polaroid Corp., Cambridge, Mass.).
In the dual-probe hybridization format we relied on si-
multaneous hybridization of both a biotin-labeled probe
and a fluorescein-labeled probe to target regions within the
PCR-amplified product (13). The 5' biotin-labeled probe,
PACABL1 (CTGACGAGGAGCAACCGA1TAAGCGCCG
TA; corresponding to nucleotides 508 to 537 [11]), and the 5'
fluorescein-labeled probe, PACAFL1 (CTTGC'1T'lAGCGG
TAGCAGAGGCTCT'IGGG; corresponding to nucleotides
930 to 959 [11]) (Applied Biosystems, Foster City, Calif.), were
designed on the basis of the internal sequence of the 622-bp
amplified fragment. A total of 20 RI of PCR product was added
along with 25 RI of hybridization buffer (30 mM sodium
phosphate, 450 mM NaCl, 3 mM EDTA, 0.25% Triton X-100;
pH 7.4) containing 120 pg of each probe. This PCR product-
probe solution was incubated at 100°C for 5 min during a
denaturation step and then incubated at 55°C for 15 min
during the hybridization step. A 100-pA portion of a streptavi-
din solution (20 pug/ml) was immediately added to the hybrid-
ization mixture, and the resulting preparation was then filtered
through a biotinylated membrane (Molecular Devices). Poly-
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FIG. 1. Sensitivity of the PCR assay as determined by PAGE and
ethidium bromide staining. Lanes 1 through 9 contained the PCR
products obtained when the starting template copy numbers were 2.7
x 107, 2.7 x 106, 2.7 x 105, 2.7 x 104, 2.7 x 103,2.7 x 102, 2.7 x
101, 2.7 x 100, and 2.7 x 10', respectively. Lane 10 shows the results
of the PCR assay when no DNA template was present.
clonal anti-fluorescein antibody conjugated to urease was then
incubated for 30 min with the streptavidin-captured probe-
PCR product complex. Excess anti-fluorescein antibody was
then washed off, and the membrane-bound urease-containing
complex was exposed to urea in a pH-sensitive silicon sensor
(6, 8). The change in pH resulting from the hydrolysis of urea
was recorded in microvolts per second. All samples were
analyzed in triplicate, and statistical significance was deter-
mined by using the Student t test.
RESULTS
Specificity and sensitivity of the PCR assay. We attempted
to amplify the targeted 622-bp fragment from 1-pug samples of
DNAs isolated from B. anthracis Ames, Vollum, New Hamp-
shire, and Sterne, as well as from various control bacteria (see
above), by using 100-pAl reaction mixtures. The expected
622-bp fragment was successfully amplified from all of the
anthrax strains except strain Sterne, which lacks plasmid pXO2
containing the capB gene (data not shown). We were not able
to amplify the targeted 622-bp fragment when we used DNA
templates obtained from C. botulinum types A and E, V
cholerae, B. megaterium, B. licheniformis, B. thuringiensis, B.
cereus, B. globigii, B. subtilis, Salmonella typhi, E. coli, Shigella
sonnei, P. aeruginosa, K pneumoniae, A. globiformis, and M.
halopoilus (data not shown). Although a PCR product of the
correct size was amplified from Y pestis, probes PACABL1
and PACAFL1 hybridized to the PCR products amplified from
the anthrax strains but not to the product amplified from Y
pestis (data not shown).
Serial 10-fold dilutions of B. anthracis Ames DNA were
prepared, and aliquots containing known quantities of DNA
corresponding to 1.4 x 10-2 to 1.4 x 107 genomic copies were
then used in the PCR assay for amplification of the 622-bp
fragment. The numbers of genomic copies used were estimates
based on the following assumptions: a single copy of plasmid
pXO2 was present in each vegetative cell (16), the average size
of plasmid pXO2 was 90 kb, and the average size of the
bacterial genome was 30 x 106 bp (2). When we used ethidium
bromide staining of PCR products after PAGE, we consistently
detected at least 1.4 x 102 copies (Fig. 1). When we used the
biosensor assay to detect PCR products (Fig. 2), we consis-
tently detected at least 2.7 copies (P < 0.05, Student's t test)
when the averages for three replicates were compared with the
averages for three negative controls containing no DNA. We
noted that the signals obtained with PCR dilutions increased
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FIG. 2. Sensitivity of the modified PCR assay as determined by the
dual-probe hybridization assay. The values are the means and standard
errors of the values obtained for three replicates.
of template copies was increased from 2.7 to 27. The signals
obtained with PCR dilutions containing 270 to 2,700 template
copies were significantly weaker (P < 0.05, Student's t test),
however, than the signals obtained with the PCR dilutions
containing 27 copies. We hypothesized that the apparent
decrease in signals at higher concentrations might have been
due to competition between the second strand of the PCR
product and the oligonucleotide probes. To prove this, in a
separate experiment, we examined serial dilutions of the
product of a PCR mixture that initially contained 1.4 x 107
template copies (Fig. 3). Our hypothesis was supported when
we observed a significant increase in signals up to a dilution of
1/1,000 compared with the initial undiluted PCR product (P <
0.05, Student's t test).
Identification of spores of B. anthracis. We attempted to
amplify DNA from B. anthracis spores by adding serial 10-fold
dilutions of unprocessed spores directly to PCR mixtures
(Table 1) and were able to detect as few as 102 unprocessed
spores per PCR mixture. Supernatants were obtained from
these 10-fold dilutions by passing spore preparations through
0.2-,um-pore-size filters, and all of the sufernatants which
corresponded to spore concentrations of 10 spores per reac-
tion mixture or greater amplified the targeted fragment.
Therefore, it appeared that the presence of spores in the PCR
mixtures resulted in an increase in sensitivity of only 1 log
above the sensitivity seen with the corresponding supernatants.
Release of DNA from unprocessed spores was, therefore,
relatively inefficient, and the major sources of DNA in the
spore preparations were clearly extracellular.
In order to facilitate the release of DNA from spores, we
compared the effect of limited spore germination with the
effect of mechanical spore disruption prior to PCR amplifica-
tion. Germination of spores in PBS supplemented with 300
mM L-alanine and 6 mM ortho-carbamyl-D-serine for 4.5 h
followed by boiling for 30 min allowed us to detect 1 spore per
PCR mixture (Table 2). Identical results were obtained when
the spores were mechanically disrupted with a mini-bead
beater for 10 min (Table 2). The two procedures, therefore,
appeared to be equally effective in causing the release of DNA
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FIG. 3. Effect of diluting the amplified PCR product on the
intensity of the signal obtained from the dual-probe hybridization
assay. The values are the means and standard errors of the values
obtained for three replicates. The starting template copy number was
2.7 x 107.
DISCUSSION
Identification of pathogenic microorganisms is sometimes
problematic, especially when cultivation is difficult or hazard-
ous. In addition, numerous reports (15) have shown that viable
but nonculturable microorganisms often constitute a signifi-
cant portion of the environmental microbial flora. Under these
circumstances, detection methods which rely on cultivation of
organisms can result in underestimation of the actual risk
posed by infectious microorganisms. PCR amplification of
infectious agents can overcome some of the limitations of the
conventional cultural methods used for isolation and detec-
tion.
In this study we developed a PCR assay to detect B. anthracis
DNA by amplifying a 622-bp region of plasmid pXO2. Virulent
B. anthracis has been shown to harbor both this plasmid and
plasmid pXO1, which contains various toxin genes described





103 287.7 ± 13.1l 283.4 ± 41.9a
102 249.3 ± 31.0a 156.7 ± 40.6
10 134.2 ± 31.6 111.8 ± 15.1
1 82.6 ± 4.8 98.6 ± 21.5
10 78.7 ± 2.3 107.0 ± 14.7
10-2 80.0 ± 3.1 89.6 ± 3.2
Negative controib 112.2 112.2
No DNA 90.0 ± 3.3 90.0 ± 3.3
a This value was significantly greater than the corresponding value for the
control containing no DNA (P < 0.05, Student's t test).
b PCR mixtures containing 0.5 ng of B. subtilis genomic DNA as the template.
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TABLE 2. Identification of germinated spores of B. anthracis by
using the PCR
Biosensor signal (,uV/s)
No. of spores Germinated Mechnically
spores disruptedspores
103 345.3 ± 12.3a NDb
102 229.5 ± 31.5a ND
10 191.1 ± 12.3a 293.6 ± 32.2
1 170.0 ± 11.8a 356.2 ± 40.3
1o-1 83.5 ± 0.5 110.6 ± 23.4
10-2 104.7 ± 13.0 106.6 ± 7.7
Negative controlc 92.8 69.6
No DNA 85.6 ± 1.2 72.0 ± 2.5
a This value was significantly greater than the corresponding value for the
control containing no DNA (P < 0.05, Student's t test).
b ND, not determined.
c PCR mixture containing 0.5 ng of B. subtilis genomic DNA as the template.
previously. Therefore, any attempt to identify virulent B.
anthracis must target genes located on both of these plasmids.
When we used primers specific to the capB region, as few as
140 copies of the target region could be amplified by using the
appropriate amplification conditions followed by PAGE and
ethidium bromide staining. When we used the dual-probe
hybridization format, it became evident that the primers were
capable of amplifying the targeted 622-bp fragment from a
single genomic copy of B. anthracis. This level of sensitivity
corresponded to our previous levels of detection sensitivity,
and no nested PCR was necessary (4). The levels of sensitivity
described above are estimates since we assumed that each
spore or vegetative cell contains a single copy of plasmid pXO2
(16), that the average size of the plasmid is 90 kb (11), and that
the average size of the bacterial genome is 30 x 106 bp (2). At
the present time, we cannot explain why we were able to
consistently amplify a DNA fragment of the proper size when
Y pestis DNA was used as the template in the PCR. We
hypothesize that Y pestis contains a gene which is partially
homologous to the capB gene ofB. anthracis since we could not
demonstrate hybridization of the two capB-specific probes to
the PCR product amplified from Y pestis DNA.
The dual-probe hybridization format used in this study
increased the sensitivity of the PCR assay above the sensitivity
which was obtained when PAGE and ethidium bromide stain-
ing were used and also ensured specificity since no electrical
output occurred unless two probes hybridized to the target.
Furthermore, the dual-probe hybridization format requires
less time (45 min) than conventional hybridization protocols.
We clearly demonstrated that at high PCR product concentra-
tions, probes appear to be inhibited from hybridizing to the
target. This inhibition may be due to competition from the
second strand which is finally overcome when the PCR product
is diluted prior to probe hybridization.
We believe that the combination of the PCR assay described
in this paper and the assay described previously (4) should
permit rapid identification of all virulent strains of B. anthracis.
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